Red X iconGreen tick iconYellow tick icon
a head shot of a man and a woman

Jayde Ngata (Ngāi Tahu, Ngāti Porou) and Fran Munro (Ngāpuhi, Ngāti Moerewa, Ngāti Rangi, Ngāti Hine) have received PhD scholarships in the Māori Cancer Researcher Awards, a joint initiative between Te Kāhui Matepukupuku o Aotearoa – Cancer Society of New Zealand, Hei Āhuru Mōwai Māori Cancer Leadership Aotearoa, established and the Gut Cancer Foundation of New Zealand.

Whānau is at the heart of cancer research projects set to be undertaken by three Otago scholarship recipients.

Jayde Ngata and Fran Munro have received PhD scholarships, and Gemella Reynolds-Hatem a Master’s scholarship in the latest Māori Cancer Researcher Awards announced today.

The awards are a joint initiative between Te Kāhui Matepukupuku o Aotearoa (the Cancer Society of New Zealand) and Hei Āhuru Mōwai Māori Cancer Leadership Aotearoa, established four years ago, and the Gut Cancer Foundation of New Zealand.

The trio is among five award recipients whose work will help improve cancer outcomes for Māori and address health inequities in Aotearoa New Zealand.

Gemella Reynolds-Hatem (Ngāi Tūāhuriri, Ngāti Hāteatea, Ngāti Waewae - Ngāi Tahu)

Gemella has received a Master’s scholarship for her work that will focus on improving outcomes for Ngāi Tahu whānau impacted by a CDH1 gene mutation, particularly breast cancer in wāhine.

Gemella will test specific drugs (capivasertib and fulvestrant) to see if they can stop tumour growth in CDH1 cancer models. Additionally, she will engage with whānau at Tuahiwi through wānanga, integrating tikanga and Māori cultural practices.

“During the last year of my undergraduate degree, a tuakana at Ōtākou Whakaihu Waka alerted me to the CDH1 gene and its impact within Ngā iwi Māori.

“After my first hui with Matua Parry I was informed of the CDH1 mutation within the iwi I whakapapa back to. To me this was a tohu from my tīpuna that this is where I am meant to be and this mahi is what I am meant to be a part of.

“I knew it was my calling to do this for my people, but to also continue the path our tuakana has begun to allow the stream of tauira Māori to continue within Te ao Pūtaiao. Mō tātou, ā, mō kā uri ā muri ake nei. For us and those after us.

“My goal is to ensure the health care system better serves our people and provides a space for our people to talk about their journey with the CDH1 mutation but to make change for Māori by Māori.

a woman working with a pipette

Gemella Reynolds-Hatem (Ngāi Tūāhuriri, Ngāti Hāteatea, Ngāti Waewae - Ngāi Tahu) has received a Master’s scholarship in the Awards for her research into the CDH1 gene mutation.

Jayde Ngata (Ngāi Tahu, Ngāti Porou)

Jayde will lead research focused on understanding how tumour bacteria can help improve the effectiveness of immunotherapy for people with colorectal (bowel) cancer.

His research will also explore the acceptability and accessibility of using tumour tissue models for research, with a particular focus on Māori bowel cancer patients and their whānau.

Jayde says his interest in cancer research began during his honours’ year.

“I became fascinated by how small molecular changes can affect the immune system and cancer development. There is still so much to learn about our connection to the gut microbiome and its influence on our overall health, particularly in the context of gut cancers.”

His passion for science more generally is deeply entwined with strong whānau support and role models, including his late Uncle Norm Dewes, a strong advocate for the community.

“My uncle always encouraged me to pursue a PhD and to fight for change in our community,” Jayde says.

“This research is my way of continuing that fight for better cancer outcomes and a better health system for all.”

Fran Munro (Ngāpuhi, Ngāti Moerewa, Ngāti Rangi, Ngāti Hine)

Fran will focus on understanding Māori perspectives on research through her PhD. She plans to talk to gastric (stomach) cancer patients and their whānau in Te Tai Tokerau (Northland) and explore their thoughts around their tissue being used in research.

“Precision medicine is a growing enterprise with the potential to improve patient outcomes. Equitable outcomes can only be achieved if Māori engagement is actively sought and consultation outcomes implemented.

“The insights gained from this PhD project could help guide the culturally safe implementation of precision medicine in Aotearoa, ensuring tangata whenua feel heard, valued, welcomed and cared for in the cancer space.”

Cancer Research at Otago

Our goal is to reduce the impact and incidence of cancer. At Otago we have a huge number of researchers working to advance the prevention, detection and management of cancer in New Zealand, and beyond.

View
No image set
Back to top